A wide variety of bioinformatic tools have been described to characterize potential transcriptional regulatory mechanisms based on genomic sequence analysis and microarray hybridization studies. However, these regulatory mechanisms are still experimentally verified using transient transfection methods. Current transfection methods are limited both by their large scale and by the low level of efficiency for certain cell types. Our goals were to develop a microarray-based transfection method that could be optimized for different cell types and that would be useful in reporter assays of transcriptional regulation. Here we describe a novel transfection method, termed STEP (surface transfection and expression protocol), which employs microarray-based DNA transfection of adherent cells in the functional analysis of transcriptional regulation. In STEP, recombinant proteins with biological activities designed to enhance transfection are complexed with expression vector DNAs prior to spotting on microscope slides. The recombinant proteins used in STEP complexes can be varied to increase the efficiency for different cell types. We demonstrate that STEP efficiently transfects both supercoiled plasmids and PCR-generated linear expression cassettes. A co-transfection assay using effector expression vectors encoding the cAMP-dependent protein kinase (PKA), as well as reporter vectors containing PKA-regulated promoters, showed that STEP transfection allows detection and quantitation of transcriptional regulation by this protein kinase. Because bioinformatic studies often result in the identification of many putative regulatory elements and signaling pathways, this approach should be of utility in high-throughput functional genomic studies of transcriptional regulation.
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The sequences of the human, mouse, and other genomes provide the basic framework for more detailed studies of the role of gene expression in human health and disease. Although detailed transcriptional control mechanisms are known for many genes, our understanding of the transcriptional regulatory circuits involved in mammalian development and homeostasis is far from complete. Better definition of these regulatory mechanisms for the human transcriptome will require advances at several levels.
First, the estimated 2,000 transcription factors (1) encoded in the human genome require further characterization. Some of these transcription factors, such as the cAMP-response element binding (CREB) 1 protein, have been well characterized in terms of structure, regulation, and recognition of cognate DNA sequences (2) . However, other transcription factors are defined only by sequence homology to other invertebrate or mammalian transcription factors (3) . Structural and functional studies of such uncharacterized transcription factors are greatly enhanced by the identification of cognate DNA binding sequences to enable functional assays of transcriptional activation.
At a second level, a more detailed understanding needs to be developed of the specific functional cis-acting regulatory sequences that control gene expression within the human genome. Although regulatory sequences in metazoan genes are known to occur as far as 10 -50 kb upstream or downstream of promoter sequences or within intronic sequences (4), most transcriptional studies currently focus on sequences within 1-2 kb of the transcriptional start site. The ability to identify possible regulatory sequences has been enhanced by bioinformatics analysis of genomic sequences, particularly with the use of phylogenetic footprinting (5, 6) . However, very few of the putative regulatory sequences identified by phylogenetic footprinting have been experimentally verified for their ability to regulate transcriptional activity.
Finally, the activity of individual transcription factors is modulated through diverse mechanisms (4) . Transcription factors may participate in heteromeric complexes, and these complexes can have distinct effects on gene transcription depending on the participating proteins. In addition, post-translational modifications, such as phosphorylation, may either activate or inactivate the transcriptional activity of an individual transcription factor. Ubiquitination, methylation, and acetylation represent further mechanisms for modulation of transcription factor activity.
In all the applications discussed above, higher throughput in transfection-based analysis could significantly increase the rate at which transcriptional regulatory mechanisms are elucidated. Currently, the transfection-based transcription reporter assay is the most widely employed in vivo method for studying the interactions of mammalian transcription factors and genomic sequences. Typically, effector constructs encoding a protein of interest are co-transfected with reporter constructs containing a specific DNA sequence required for binding of a particular transcription factor. For example, cotransfection of a protein kinase expression vector together with different promoter-reporter constructs can be used to identifiy cis-acting elements within the promoter that are responsible for transcriptional regulation by the protein kinase. These transfection-based assays are usually performed on a scale using micrograms of DNA and millions of cells, making high throughput difficult and restricting the experimental parameters of the assay.
Here we report the development of a novel transfection method, termed surface transfection and expression protocol (STEP), using only nanograms of DNA and hundreds of cells to study transcriptional regulation. During STEP, complexes are formed between DNA molecules to be transfected and recombinant proteins that are engineered to mediate the highefficiency transfection of cells. The complexes are applied to the surface of glass slides utilizing the same standard microarrayers used for hybridization analysis. After drying of the complexes, cells are passaged onto the slide and the cells are transfected after adherence to the slide surface. We report here that this STEP method has been optimized for neuronal cell lines using GFP reporter constructs and has been employed for the quantitative analysis of PKA regulation of cAMP-responsive reporters.
MATERIALS AND METHODS
Expression Vectors-Synthetic oligonucleotides (GGGGAATTCTT-CTTGTATTCCCCTTAGTATGC and GGGAAGCTTGCTGGGCGATAT-AAGGATGGAC) were used to amplify the adenoviral penton protein from human adenovirus type 5 genomic DNA (Clontech, Palo Alto, CA). The resulting 1.7-kb fragment was subcloned into EcoRI-and HindIII-digested pET28a DNA to generate the pET-Penton vector. The pET-Tat-Penton vector was constructed by digesting the pET-Penton vector with EcoRI and inserting the annealed Tat oligonucleotides (AATTCGGATACGGACGGAAAAAGCGGAGACAGAGACGGAGA-GGCC and AATTGGCCTCTCCGTCTCTGTCTCCGCGGGGGCCGT-CCGTATCCG).
A 500-bp fragment of the human c-fos promoter was amplified using the oligonucleotides (GGGAGATCTGCAGCCCGCGAGCAGTT and GGGGAATTCCGAGGGGCGGAGACAGGTG). Both of these fragments were subcloned into EcoRI-and BglII-digested pEGFP-1 or pd2EGFP-1 (Clontech).
The plasmids pCMV.Neo, pCMV.C␣, and pCMV.C␤ have been described previously (7) . The pEGFP-C1, pDsRed2-C1 and pCREd2EGFP plasmids were obtained from Clontech. Plasmid DNAs were purified by ethidium bromide-CsCl density gradient centrifugation (8) .
Protein Purification-The adenoviral penton protein, HIV Tat protein, and Tat-penton fusion proteins were expressed in Rosetta cells (Novagen, Madison, WI) and purified using Ni 2ϩ -nitrilotriacetic acid affinity chromatography (Qiagen, Valencia, CA). Preparations of proteins were diluted to concentrations ranging from 0.002 to 2 mg/ml and assayed for cell transfection as described below. Subsequently, the entire preparation was diluted to the optimal concentration (typically 0.02 mg/ml) and stored at Ϫ20°C.
PCR Amplification of a Green Fluorescent Protein (GFP) Expression Cassette-Oligonucleotides corresponding to sequences 5Ј of the cytomegalovirus (CMV) promoter (TTGTCCAAACTCCTAAATGTA-TCT) and 3Ј of the human growth hormone poly(A) addition sequence (TTGTAAAACGACGGCCAGTGAAT) were used to amplify a 2.4-kb fragment corresponding to the CMV promoter, C␤-coding sequence, and human growth hormone polyadenylation sequence of the pC-MV.C␤ plasmid (7) . Oligonucleotides corresponding to sequences 5Ј of the cAMP response element (CRE) (TGGAGCGGCCGCAATA-AAATA) and 3Ј of the SV40 polyadenylation sequence (TCCCCCT-GAACCTGAAACATAAAA) were used to amplify a 1.5-kb fragment corresponding to the promoter, GFP-coding region, and SV40 polyadenylation region of pCRE-d2EGFP (Clontech).
STEP Transfection-For the typical STEP transfection, all plasmid DNAs were diluted to 0.12 mg/ml in water. For co-transfection assays, these stocks were mixed to give the proportions indicated (e.g. 5% CMV.PKA␤). Three microliters of the mixed plasmid DNAs to be transfected were added to one well of a 96-well microtiter plate. STEP complexes were formed by the sequential addition of 3 l of a protein complex (transferrin-poly-L-lysine conjugate (Sigma, St. Louis, MO), penton protein, Tat-penton protein, etc.) and 3 l of a cationic lipid (2 mg/ml lipofectamine, lipofectamine 2000 (Life Technologies, Inc., Grand Island, NY), or other lipids). The resulting solution was incubated for 20 min at room temperature. Typically, the turbidity of the solution increased as the complexes formed, and microscopic particles could be observed by light microscopy at the end of the 20-min incubation. If indicated, additional factors, such as lyoprotectants (glycerol, sucrose) or cell adhesion factors (fibronectin, collagen, laminin), were added in a final 1-l addition. All GFP reporter vectors used commercially available variant GFP proteins with point mutations to enhance GFP fluorescence.
Microarray Printing-Microarrays were printed using a Microgrid II Compact arrayer from BioRobotics (San Carlos, CA). DNA complexes were loaded into 384-well plates (Genetix, Hampshire, United Kingdom) and printed on polylysine-coated slides (Electron Microscopy Sciences, Hatfield, PA) using solid 0.7-mm pins (Apogent, Portsmouth, NH). Pins were dipped twice into the sample plate, and the complex was deposited on the slide using a 1-s dwell, under relative humidity conditions of 65-75%. Spots were spaced 1.8 mm apart. Complexes were spotted three times to the same location, allowing time for complete drying between applications. The high humidity and triplicate spotting were critical for high-efficiency transfection.
Cell Plating-Exponentially growing cells (HEK-293T, SH-SY5Y, N2A, or PC-12) in Dulbecco's modified Eagles medium with 10% fetal calf serum were trypsinized and plated at the cell densities indicated (e.g. 5 ϫ 10 6 /ml) by placing 9 ml of the cell suspension over the microscope slide in one well of a quadriPERM plate (Vivascience, Gö ttingen, Germany). During the period of 1 h, most of the cells settled by sedimentation onto the slide surface. The quadriPERM plate has four wells, each of which is designed to hold a single 25-mm ϫ 75-mm microscope slide, and the addition of 9 ml of cell suspension resulted in an initial confluency of 20 -80% on the slide surface for the cell densities indicated (0.5-2.0 ϫ 10 6 /ml). Imaging and Analysis-Fluorescence microscopy of live cells was usually performed 48 h after plating with an inverted Olympus IX70 fluorescence microscope using an Illix CCD imaging system and MicroComputer Image Device software (Imaging Research, Inc., St. Catherines, Ontario, Canada) for pixel density histogram analysis. For slide scanning, cells on the slides were fixed in 100% methanol at Ϫ20°C, and images were obtained by scanning the slides using a white-light CCD camera scanner (arrayWorx 'e'; Applied Precision, Issaquah, WA) at 13.25-m resolution. GFP and DsRed2 emission was visualized by using the GFP (480/520) and Cy3 filter set (Chroma, Rockingham, VT). Images were pseudo-colored using the arrayWorx 'e' software. Fluorescence intensity was collected using the Digital Genome software (Applied Precision), exporting the total spot intensity. Error bars indicate the standard deviation of the triplicate or quadruplicate fluorescence measurements.
RESULTS
Microarray transfection offers many potential advantages over solution transfection, including higher throughput, greater consistency across assays, and reductions in cell numbers required for cell types that are difficult to prepare. The method of reverse transfection has been reported previously in microarray transfection (9) . Reverse transfection uses a commercially available lipid for transfection and gelatin to immobilize the lipid-DNA complexes to the slide surface. In our studies, we found two major disadvantages of reverse transfection. First, the method is not able to mediate high-efficiency transfection of many neuronal cell lines. Second, reverse transfection was not able to detect functional interactions in a cotransfection assay of an effector vector and a reporter vector.
In an effort to develop a method for co-transfection assays of transcriptional regulation in a microarray format in neuronal cell lines, we employed recombinant proteins known to facilitate transfection to develop STEP. Several proteins have previously been shown to increase the solution-mediated transfection efficiency, including transferrin (10), the adenoviral penton protein (11) , and the HIV Tat protein (12) . These proteins have not previously been applied to surface-mediated microarray transfection.
We developed STEP so that transfection complexes containing recombinant proteins could be optimized for individual cell types, using the biological functions of peptide sequences known to enhance transfection. Five different protein functionalities have been employed thus far: 1) amino acid sequences that bind to the nucleic acid to be transfected; 2) sequences that bind to cell-surface receptors and facilitate endocytosis of the DNA to be transfected; 3) sequences that facilitate the passage of proteins across membranes; 4) proteins that target DNA to the nucleus; and 5) proteins that promote the adherence or survival of cells on the STEP complex. We prepared STEP complexes of plasmid DNA with several proteins and applied the complexes to microscope slides using a robotic DNA microarrayer, as described in "Materials and Methods." After drying of the complexes onto the microscope slide, mammalian cells were passaged onto the slides, using standard tissue culture techniques, and then cultured. Under ideal conditions, cells plated onto the spotted complexes developed intracellular GFP fluorescence over the time course of 12-72 h, with maximal fluorescence occurring between 24 and 48 h after cell plating (data not shown).
Many factors were optimized in the process of developing STEP transfection. First, the DNA in the STEP complex must adhere to the glass slide. Free DNA and many protein complexes do not adhere well to the slide surface. Second, the DNA complex should be evenly distributed over the spot after the complex has dried. Spotting under conditions of high humidity and the inclusion of glycerol or sucrose to the STEP complexes facilitated this even distribution. Third, the complexes must be optimized for the number of cells adhering to the spotted STEP complex. Some complexes do not promote the adherence or survival of cells and therefore exhibit low (1) 0.06 g/ml DNA, penton protein, LipofectAMINE 2000, 2.5% sucrose; (2) 0.12 g/ml DNA, penton protein, LipofectAMINE 2000, 2.5% sucrose; (3) 0.24 g/ml DNA, penton protein, LipofectAMINE 2000, 2.5% sucrose; (4) 0.48 g/ml DNA, penton protein, LipofectAMINE 2000, 2.5% sucrose; (5) 0.12 g/ml DNA, Tat-penton protein, LipofectAMINE; (6) 0.12 g/ml DNA, Tat-penton protein, LipofectAMINE, 2.5% sucrose; (7) 0.12 g/ml DNA, Tat-penton protein, LipofectAMINE, fibronectin; (8) 0.12 g/ml DNA, Tat-penton protein, LipofectAMINE, 10% glycerol; (9) 0.12 g/ml DNA, penton protein, LipofectAMINE 2000; (10) 0.12 g/ml DNA, penton protein, LipofectAMINE 2000, 2.5% sucrose; (11) 0.12 g/ml DNA, penton protein, LipofectAMINE 2000, fibronectin; (12) 0.12 g/ml DNA, penton protein, LipofectAMINE 2000, 10% glycerol; (13) 0.12 g/ml DNA, transferrin-polylysine, LipofectAMINE; (14) 0.12 g/ml DNA, transferrin-polylysine, LipofectAMINE; 2.5% sucrose: (15) 0.12 g/ml DNA, transferrin-polylysine, LipofectAMINE; fibronectin; (16) 0.12 g/ml DNA, transferrin-polylysine, LipofectAMINE; 10% glycerol. B, GFP fluorescence micrograph of HEK-293T cells plated onto the 16 STEP complexes described above after fixation and scanning with a fluorescence slide scanner. C, GFP fluorescence micrograph of N2A neuroblastoma cells plated onto the 16 STEP complexes. D, GFP fluorescence micrograph of SHSY-5Y cells plated onto the 16 STEP complexes. The length of the bars in the lower right panel is 500 m. E, Quantitation of HEK-293T cells transfected with the complexes shown in A. Cells were plated at three different densities (2 ϫ 10 6 cells/ml (white bars); 1 ϫ 10 6 cells/ml (gray bars); and 0.5 ϫ 10 6 cells/ml (black bars)), and then incubated on the slides containing the spotted complexes for 48 h. After fixation in methanol, the slides were scanned using a fluorescence slide scanner and the GFP fluorescence quantitated as described in "Materials and Methods." F, quantitation for Neuro2A neuroblastoma cells. G, quantitation for SH-SY5Y neuroblastoma cells. H, quantitation for PC-12 pheochromocytoma cells. Fig. 1 demonstrates that STEP can mediate the high-efficiency transfection of the SH-SY5Y neuroblastoma cells. An expression vector encoding the GFP was complexed with the adenoviral penton protein as described in "Materials and Methods," and the STEP complex was spotted onto a microscope slide. SH-SY5Y cells were trypsinized and allowed to sediment onto the surface of the slide. Forty-eight hours later, live cells were imaged by fluorescence microscopy, and ϳ60% of the cells on the STEP complex were found to express GFP. This level of efficiency compares favorable to the 6 -10% transfection efficiency reported previously for SH-SY5Y cells (13, 14) .
Several variables had dramatic effects on transfection efficiency. The optimal conditions for any particular cell type are best determined through the use of an optimization array of different complex formulations. Fluorescence micrographs of fixed cells following a small-scale transfection optimization experiment for three different cell lines are shown in Fig. 2 . This experiment demonstrates some important factors with regard to transfection optimization. First, the amount of DNA used in the STEP transfection is critical, as shown by comparison of the cellular fluorescence corresponding to spots 1-4 of Fig. 2B . Optimal transfection generally occurs when complexes are formed with a DNA concentration of 0.12 mg/ml, corresponding to ϳ360 ng of total plasmid DNA on a 700-m spot. Second, the HEK-293T cells are transfected more efficiently with complexes formed with the recombinant adenoviral penton protein, compared with complexes formed with either transferrin-polylysine or the Tat-penton fusion protein. However, the transfection efficiency of transferrin-polylysine can be increased significantly in the presence of the cell attachment factor fibronectin (Fig. 2B, spots 13 and 15) . Finally, the addition of lyoprotectants such as 2.5% sucrose significantly enhances transfection of HEK-293T cells (Fig. 2B , spots 9 and 10), but addition of glycerol does not enhance transfection (Fig. 2B, spots 9 and 12 ).
The overall fluorescence of cells on an individual STEP complex varies among different cell types (Fig. 2) . Although the Tat-penton protein shows significantly lower fluorescence for HEK-293T cells and N2A neuroblastoma cells (spot 6 in Fig. 2, B and C) , it is one of the most efficient complexes for GFP transfection of the SH-SY5Y neuroblastoma cells (Fig.  2D, spot 6) . Likewise, although transferrin-polylysine supplemented with fibronectin is a moderately efficient complex for HEK-293T cells, it is not effective for N2A neuroblastoma cells and is only moderately effective for SH-SY5Y cells.
The fluorescence micrographs like those shown in Fig. 2 , B-D, were analyzed in quadruplicate at three different cell densities, and the results are shown in Fig. 2 , E-H. The effect of cell density is variable for different cell types, with HEK-293T, N2A, and SH-SY5Y cells showing increased fluorescence with increasing cell density, while PC-12 cells show a decrease in fluorescence at the highest cell density. The absolute level of GFP fluorescence for individual cell types varies significantly, with the optimized fluorescence signal being 10-fold higher for HEK-293T and N2A cells than for SH-SY5Y or PC-12 cells. This difference in the fluorescence intensity was not due to differences in transfection efficiency because the optimized transfection resulted in 50 -80% GFPpositive cells for all the cell types shown (Fig. 3) . These variations likely reflect different levels of GFP expression in each individual cell (Fig. 3 ).
All the experiments described above employed supercoiled plasmid vectors in order to characterize STEP transfection. Because PCR can potentially produce multiple linear expression vectors more rapidly than bacterial growth of plasmid vectors, we determined whether a PCR-generated linear expression cassette (15) could be used in STEP transfection. Fig. 4 shows a fluorescence micrograph demonstrating that a linear expression cassette for GFP was transfected efficiently into HEK-293T cells under the same conditions that are optimized for transfection of plasmid expression vectors. After identification of the optimal transfection conditions for the various cell types, we sought to determine whether the amount of cellular fluorescence resulting from transfection of GFP expression vector could be determined in a manner that would allow the development of a quantitative transcriptional reporter assay. Transfection complexes were formed containing varying proportions of a GFP expression vector with a fixed total DNA concentration. The STEP transfection of these complexes resulted in cellular fluorescence that was linear with the proportion of GFP expression vector used (Fig. 5A) . Furthermore, levels of GFP fluorescence similar to the plasmid DNA were observed for a linear expression cassette consisting of the CMV promoter, GFP-coding region, and SV40 polyadenylation sequence (Fig. 5B) .
After optimization of the transfection process, we sought to determine whether STEP transfection could be used in a co-transfection-based reporter assay using an effector expression vector for a protein kinase and a reporter expression vector containing a regulatory DNA sequence directing expression of GFP. However, we first tested whether co-transfection efficiency was detected following STEP transfection. As shown in Fig. 6 , it was noted during experiments using GFP and DsRed expression vectors that co-transfection efficiencies determined by GFP and DsRed fluorescence were greater than 95%.
In order to define the transfection parameters that were suitable for the detection of transcriptional regulation by a GFP reporter, we used as a model system the well-characterized regulation of CRE by cAMP-dependent protein kinase (PKA). Co-transfection of the catalytic subunit of PKA has previously been shown to increase CRE-containing luciferase and chloramphenicol acetyl transferase reporters (16, 17) . Because initial experiments using standard plasmid DNA mixtures containing 5-10% of the transfected DNA as reporter did not show regulated GFP fluorescence, we used a wider range of ratios of reporter (pCRE-d 2 EGFP) and effector (pC-MV.PKA␤), increasing the range from 5% reporter and 90% effector to 90% reporter and 5% effector. As shown in Fig. 7 , we found that the highest levels of regulation were obtained when the reporter construct constituted 50% or more of the plasmid DNA. This was surprising, because most reporter assays using solution transfection are optimized when the reporter is less than 10% of the total DNA transfected. The observation that reporter assays using STEP transfection were optimal when a majority of the DNA was reporter was also repeated with other reporter constructs, such as an Elk-1 reporter, a c-myc reporter, and a c-fos reporter (data not shown). We also found that when the effector plasmid was expressed as a linear PCR amplification cassette, regulation of the reporter plasmid by co-transfection of the PKA C subunit could be detected (Fig. 7) . However, regulation was not observed if the reporter construct was generated as a linear amplification cassette (Fig. 7) . Similar results were also found if the reporter plasmid DNA was linearized by restriction enzyme digestion. Thus it appears that supercoiling of the reporter plasmid is critical, while supercoiling of the effector plasmid is not. Co-transfection of an expression vector for PKA increased GFP expression by 2-to 5-fold. This induction was dependent on the presence of the CRE: the fluorescence resulting from transfection of the parental plasmid lacking CREs (pTAL-d 2 EGFP) was not detectable (data not shown).
The dependence of the transcriptional regulation on coexpression of PKA was examined in more detail for three different transcriptional reporters containing function CREs. The CRE-d 2 EGFP reporter has two tandem copies of the CRE upstream of a minimal promoter driving expression of a proteolytically destabilized form of GFP. The c-fos-d 2 EGFP was constructed as described in "Materials and Methods," using 400 bp of the human c-fos promoter to drive expression of the destabilized d 2 EGFP (8) . Finally, the c-fos EGFP was constructed in the pEGFP-1 reporter in which the GFP is not destabilized. Complexes were prepared with varying amounts of the PKA expression vector but with constant amounts of both the CRE-containing GFP reporter and an internal standard DsRed plasmid to control for transfection efficiency. As shown in Fig. 8 , increasing the amount of PKA expression vector resulted in increasing GFP expression from all of the CRE-containing reporters. The CRE-d 2 EGFP reporter showed a low basal level of expression and a 2.1-fold induction by PKA. The c-fos-d 2 EGFP showed a significantly higher level of basal expression and a 2.9-fold induction. The higher basal level of expression seen for the c-fos-d 2 EGFP is likely due to the presence of additional transcription factor binding sites in the fos-d 2 EGFP reporter relative to the CRE-d2EGFP. Finally, the c-fos EGFP reporter demonstrated a 3.9-fold induction by PKA co-expression and a basal level of expression similar to that of the c-fos-d 2 EGFP. From these experiments and from studies with other promoters (data not shown), we concluded that the shorter proteolytic half-life of the destabilized form of GFP was not advantageous in STEP-mediated analysis of transcriptional regulation.
A major advantage of STEP transfection is the ease with which identical transfections can be carried out for different cell types or under different culture conditions. Fig. 9 shows the results of a time-course experiment with identical STEP complexes were prepared for transfection of HEK-293T (A) and N2A neuroblastoma (B). The c-fos promoter driving GFP expression was used in these experiments, and the amounts of PKA plasmid varied from 0 to 5%. Individual microscope slides with the transfected cells attached were fixed and scanned at 12, 24, or 36 h after plating the cells. Transfection with an enhancerless control vector (pTal-d2EGFP) showed no induction of expression (data not shown). The basal expression of the c-fos reporter increased over time in the HEK-293T cells. The maximal fold induction was 3.8-fold at 12 and 24 h after transfection, but only 2.7-fold after 36 h. In HEK-293T cells, the transfection was maximized at 2.5% effector, as there was no statistically significant difference in response for 2.5 and 10% effector.
In N2A cells (Fig. 9B) , the basal level of expression of the fos promoter was approximately half that observed in HEK-293T cells, and the fold induction by PKA was less (2.3-versus 3.8-fold). The amount of PKA effector plasmid required for induction was also significantly greater for the N2A cells than for the HEK-293T cells (5 versus 2.5%). Because the complexes used in the transfection of these two cell types were identical, these results suggest that inherent differences in the signaling pathways of these two cell types results in differential responses to transfection of the PKA expression vector.
DISCUSSION
In these studies, several proteins were shown to mediate high-efficiency transfection of DNAs in a microarray format. The proteins used here include the transferrin receptor, polylysine, adenoviral penton protein, and the HIV Tat protein, although it is clear from previous work that other proteins may also be able to mediate high-efficiency transfection (18, 19) . The combinatorial use of different recombinant proteins in the spotted complexes should allow the generation of transfection complexes that are effective for a wide variety of cell types.
By using these proteins in STEP transfection, it was possible to demonstrate transcriptional regulation of a number of reporters by co-expression of the catalytic subunit of PKA. This was anticipated from the high co-transfection efficiency observed for STEP; however, the unusually high proportion of reporter plasmid required to demonstrate transcriptional regulation was not anticipated based on standard reporter assays using solution transfection. This suggests that other fundamental differences may exist between STEP transfection and solution transfection.
The magnitude of the regulation seen here is comparable to other reports of PKA regulation. For example, a c-fos luciferase construct was regulated 7-fold by co-transfection with a PKA expression vector (16) , and a c-fos EGFP reporter was shown to be induced 4-fold by serum treatment (20) . In our experiments, a reporter containing a simple CRE sequence was responsive to PKA co-transfection, but the native c-fos promoter showed a higher basal level of expression and greater ease of detection. In contrast to previous studies, our results show that the use of a destabilized form of the GFP protein was not advantageous over the wild-type protein. This may be due to the fact that the regulatory stimulus, overexpression of PKA, was present during the entire course of the experiment, while the previous studies used a shorter-term stimulation of the cells (21) .
STEP transfection was developed using supercoiled plasmids for transfection, but linear expression cassettes coding for effector proteins also regulated reporter expression. However, CRE-containing linear reporter constructs were not effectively regulated under the same transfection conditions. This would suggest that supercoiling of reporter constructs is important for the recognition by the relevant transcription factors. The ability to use linear expression cassettes of effector proteins should facilitate rapid structure function analysis of protein kinases and other signaling proteins using PCR-based mutagenesis strategies.
In addition to the identification of other proteins with the ability to enhance transfection, the utility of STEP transfection will be enhanced by the development of increasingly quantitative and more-sensitive reporter assays. In addition to GFP and other fluorescent proteins, we have also tested ␤-galactosidase, ␤-lactamase, and alkaline phosphatase reporter constructs in STEP experiments. The GFP reporters currently offer the greatest reproducibility in assay of reporter expression, despite the greater sensitivity of these other enzymatic reporters.
STEP transfection has several advantages over classical transfection. First, the scale of the transfection allows the use of nanograms, instead of micrograms, of DNA in the transfection. This reduces both the time and material required for transfection analysis. Second, the throughput for microarray transfection is much higher than for conventional transfection, with 500 -5,000 transfections per slide. Third, because all the cells are incubated in the same culture media and all the cells plated are treated identically, comparison between different effector or reporter constructs is facilitated by the large number of individual transfection reactions that STEP allows. Finally, once multiple copies of transfection microarray slides are generated, these arrays can be used for transfection of multiple cell types. Because of these advantages, the STEP transfection method has application in several types of functional genomic studies. For example, the specific physiological substrate proteins are not yet known for almost half of the protein kinases predicted in the human genome (22) . Because many protein kinases do alter transcriptional regulation, STEP analysis should be useful in identifying transcription factors regulated by these kinases. STEP could also be applied in the analysis of the regulatory sequences for genes that are identified in microarray hybridization studies. For transcripts shown to be altered in expression in microarray hybridization studies, STEP transfection would facilitate subsequent analysis of the transcriptional regulatory sequences for the corresponding gene. Finally, a large number of functional microarray-based assays not involving transcriptional reporters, such as cellular differentiation assays, cytoskeletal reorganization, and cell adhesion assays, should be possible with the same STEP transfection methods described here to enhance highthroughput functional genomic studies.
